nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Mefloquine—ABCB1—melanoma	0.00548	1	CrCbGaD
Flecainide—Pneumonia—Bleomycin—melanoma	0.00296	0.00406	CcSEcCtD
Flecainide—Hypotension—Vemurafenib—melanoma	0.00289	0.00398	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00282	0.00388	CcSEcCtD
Flecainide—Haematuria—Bleomycin—melanoma	0.0028	0.00385	CcSEcCtD
Flecainide—Neuropathy—Docetaxel—melanoma	0.00277	0.0038	CcSEcCtD
Flecainide—Pneumonia—Dactinomycin—melanoma	0.00276	0.00379	CcSEcCtD
Flecainide—Sweating increased—Temozolomide—melanoma	0.00271	0.00372	CcSEcCtD
Flecainide—Decreased appetite—Vemurafenib—melanoma	0.00269	0.0037	CcSEcCtD
Flecainide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00267	0.00367	CcSEcCtD
Flecainide—Fatigue—Vemurafenib—melanoma	0.00267	0.00367	CcSEcCtD
Flecainide—Constipation—Vemurafenib—melanoma	0.00264	0.00364	CcSEcCtD
Flecainide—Lightheadedness—Docetaxel—melanoma	0.00264	0.00363	CcSEcCtD
Flecainide—Hypoaesthesia—Bleomycin—melanoma	0.00262	0.00361	CcSEcCtD
Flecainide—Pulmonary oedema—Docetaxel—melanoma	0.00262	0.00361	CcSEcCtD
Flecainide—Dysuria—Temozolomide—melanoma	0.0026	0.00358	CcSEcCtD
Flecainide—Hyperglycaemia—Carmustine—melanoma	0.00259	0.00357	CcSEcCtD
Flecainide—Pneumonia—Carmustine—melanoma	0.00258	0.00355	CcSEcCtD
Flecainide—Erectile dysfunction—Temozolomide—melanoma	0.00256	0.00352	CcSEcCtD
Flecainide—Agranulocytosis—Dactinomycin—melanoma	0.00256	0.00352	CcSEcCtD
Flecainide—Photosensitivity reaction—Temozolomide—melanoma	0.00254	0.00349	CcSEcCtD
Flecainide—Renal failure—Carmustine—melanoma	0.00252	0.00347	CcSEcCtD
Flecainide—Neuropathy peripheral—Carmustine—melanoma	0.00251	0.00346	CcSEcCtD
Flecainide—Hyperglycaemia—Temozolomide—melanoma	0.00251	0.00345	CcSEcCtD
Flecainide—Pneumonia—Temozolomide—melanoma	0.00249	0.00343	CcSEcCtD
Flecainide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00246	0.00338	CcSEcCtD
Flecainide—Flushing—Bleomycin—melanoma	0.00245	0.00337	CcSEcCtD
Flecainide—Body temperature increased—Vemurafenib—melanoma	0.00244	0.00336	CcSEcCtD
Flecainide—Neuropathy peripheral—Temozolomide—melanoma	0.00243	0.00334	CcSEcCtD
Flecainide—Deafness—Docetaxel—melanoma	0.00239	0.00329	CcSEcCtD
Flecainide—Hepatic failure—Docetaxel—melanoma	0.00238	0.00327	CcSEcCtD
Flecainide—Cardiac failure congestive—Docetaxel—melanoma	0.00236	0.00324	CcSEcCtD
Flecainide—Alopecia—Bleomycin—melanoma	0.00233	0.00321	CcSEcCtD
Flecainide—Hallucination—Carmustine—melanoma	0.00229	0.00315	CcSEcCtD
Flecainide—Hypoaesthesia—Carmustine—melanoma	0.00229	0.00315	CcSEcCtD
Flecainide—Flushing—Dactinomycin—melanoma	0.00228	0.00314	CcSEcCtD
Flecainide—Visual disturbance—Docetaxel—melanoma	0.00226	0.0031	CcSEcCtD
Flecainide—Asthenia—Vemurafenib—melanoma	0.00222	0.00305	CcSEcCtD
Flecainide—Visual impairment—Carmustine—melanoma	0.00222	0.00305	CcSEcCtD
Flecainide—Hypoaesthesia—Temozolomide—melanoma	0.00221	0.00304	CcSEcCtD
Flecainide—Hallucination—Temozolomide—melanoma	0.00221	0.00304	CcSEcCtD
Flecainide—Pruritus—Vemurafenib—melanoma	0.00219	0.00301	CcSEcCtD
Flecainide—Alopecia—Dactinomycin—melanoma	0.00217	0.00299	CcSEcCtD
Flecainide—Eye disorder—Carmustine—melanoma	0.00215	0.00296	CcSEcCtD
Flecainide—Visual impairment—Temozolomide—melanoma	0.00214	0.00295	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00214	0.00294	CcSEcCtD
Flecainide—Flushing—Carmustine—melanoma	0.00214	0.00294	CcSEcCtD
Flecainide—Ill-defined disorder—Bleomycin—melanoma	0.00213	0.00293	CcSEcCtD
Flecainide—Diarrhoea—Vemurafenib—melanoma	0.00212	0.00291	CcSEcCtD
Flecainide—Eye disorder—Temozolomide—melanoma	0.00208	0.00286	CcSEcCtD
Flecainide—Tinnitus—Temozolomide—melanoma	0.00207	0.00285	CcSEcCtD
Flecainide—Malaise—Bleomycin—melanoma	0.00207	0.00285	CcSEcCtD
Flecainide—Flushing—Temozolomide—melanoma	0.00206	0.00284	CcSEcCtD
Flecainide—Leukopenia—Bleomycin—melanoma	0.00206	0.00283	CcSEcCtD
Flecainide—Dizziness—Vemurafenib—melanoma	0.00205	0.00281	CcSEcCtD
Flecainide—Alopecia—Carmustine—melanoma	0.00203	0.0028	CcSEcCtD
Flecainide—Ataxia—Docetaxel—melanoma	0.00201	0.00277	CcSEcCtD
Flecainide—Immune system disorder—Temozolomide—melanoma	0.00201	0.00276	CcSEcCtD
Flecainide—Cough—Bleomycin—melanoma	0.002	0.00276	CcSEcCtD
Flecainide—Ill-defined disorder—Dactinomycin—melanoma	0.00199	0.00273	CcSEcCtD
Flecainide—Vomiting—Vemurafenib—melanoma	0.00197	0.0027	CcSEcCtD
Flecainide—Alopecia—Temozolomide—melanoma	0.00197	0.0027	CcSEcCtD
Flecainide—Chest pain—Bleomycin—melanoma	0.00195	0.00269	CcSEcCtD
Flecainide—Myalgia—Bleomycin—melanoma	0.00195	0.00269	CcSEcCtD
Flecainide—Rash—Vemurafenib—melanoma	0.00195	0.00268	CcSEcCtD
Flecainide—Dermatitis—Vemurafenib—melanoma	0.00195	0.00268	CcSEcCtD
Flecainide—Headache—Vemurafenib—melanoma	0.00194	0.00267	CcSEcCtD
Flecainide—Discomfort—Bleomycin—melanoma	0.00193	0.00266	CcSEcCtD
Flecainide—Malaise—Dactinomycin—melanoma	0.00193	0.00266	CcSEcCtD
Flecainide—Leukopenia—Dactinomycin—melanoma	0.00192	0.00264	CcSEcCtD
Flecainide—Dysgeusia—Temozolomide—melanoma	0.0019	0.00261	CcSEcCtD
Flecainide—Confusional state—Bleomycin—melanoma	0.00189	0.0026	CcSEcCtD
Flecainide—Vision blurred—Carmustine—melanoma	0.00189	0.0026	CcSEcCtD
Flecainide—Tremor—Carmustine—melanoma	0.00188	0.00258	CcSEcCtD
Flecainide—Oedema—Bleomycin—melanoma	0.00187	0.00258	CcSEcCtD
Flecainide—Nausea—Vemurafenib—melanoma	0.00184	0.00253	CcSEcCtD
Flecainide—Thrombocytopenia—Bleomycin—melanoma	0.00183	0.00252	CcSEcCtD
Flecainide—Vision blurred—Temozolomide—melanoma	0.00183	0.00251	CcSEcCtD
Flecainide—Myalgia—Dactinomycin—melanoma	0.00182	0.00251	CcSEcCtD
Flecainide—Bronchospasm—Docetaxel—melanoma	0.00182	0.0025	CcSEcCtD
Flecainide—Tremor—Temozolomide—melanoma	0.00181	0.0025	CcSEcCtD
Flecainide—Discomfort—Dactinomycin—melanoma	0.0018	0.00248	CcSEcCtD
Flecainide—Angina pectoris—Docetaxel—melanoma	0.0018	0.00248	CcSEcCtD
Flecainide—Ill-defined disorder—Temozolomide—melanoma	0.0018	0.00247	CcSEcCtD
Flecainide—Leukopenia—Carmustine—melanoma	0.00179	0.00247	CcSEcCtD
Flecainide—Anorexia—Bleomycin—melanoma	0.00179	0.00246	CcSEcCtD
Flecainide—Hypotension—Bleomycin—melanoma	0.00175	0.00241	CcSEcCtD
Flecainide—Oedema—Dactinomycin—melanoma	0.00175	0.0024	CcSEcCtD
Flecainide—Malaise—Temozolomide—melanoma	0.00175	0.0024	CcSEcCtD
Flecainide—Vertigo—Temozolomide—melanoma	0.00174	0.00239	CcSEcCtD
Flecainide—Convulsion—Carmustine—melanoma	0.00174	0.00239	CcSEcCtD
Flecainide—Leukopenia—Temozolomide—melanoma	0.00173	0.00238	CcSEcCtD
Flecainide—Hypertension—Carmustine—melanoma	0.00173	0.00238	CcSEcCtD
Flecainide—Palpitations—Temozolomide—melanoma	0.00171	0.00235	CcSEcCtD
Flecainide—Thrombocytopenia—Dactinomycin—melanoma	0.00171	0.00235	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00171	0.00235	CcSEcCtD
Flecainide—Chest pain—Carmustine—melanoma	0.00171	0.00235	CcSEcCtD
Flecainide—Myalgia—Carmustine—melanoma	0.00171	0.00235	CcSEcCtD
Flecainide—Anxiety—Carmustine—melanoma	0.0017	0.00234	CcSEcCtD
Flecainide—Cough—Temozolomide—melanoma	0.00169	0.00232	CcSEcCtD
Flecainide—Paraesthesia—Bleomycin—melanoma	0.00168	0.00231	CcSEcCtD
Flecainide—Convulsion—Temozolomide—melanoma	0.00168	0.00231	CcSEcCtD
Flecainide—Hypertension—Temozolomide—melanoma	0.00167	0.0023	CcSEcCtD
Flecainide—Dyspnoea—Bleomycin—melanoma	0.00167	0.0023	CcSEcCtD
Flecainide—Anorexia—Dactinomycin—melanoma	0.00167	0.00229	CcSEcCtD
Flecainide—Pneumonia—Docetaxel—melanoma	0.00166	0.00228	CcSEcCtD
Flecainide—Confusional state—Carmustine—melanoma	0.00165	0.00227	CcSEcCtD
Flecainide—Arthralgia—Temozolomide—melanoma	0.00165	0.00227	CcSEcCtD
Flecainide—Myalgia—Temozolomide—melanoma	0.00165	0.00227	CcSEcCtD
Flecainide—Anxiety—Temozolomide—melanoma	0.00164	0.00226	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00164	0.00225	CcSEcCtD
Flecainide—Oedema—Carmustine—melanoma	0.00164	0.00225	CcSEcCtD
Flecainide—Discomfort—Temozolomide—melanoma	0.00163	0.00224	CcSEcCtD
Flecainide—Decreased appetite—Bleomycin—melanoma	0.00163	0.00224	CcSEcCtD
Flecainide—Renal failure—Docetaxel—melanoma	0.00162	0.00223	CcSEcCtD
Flecainide—Neuropathy peripheral—Docetaxel—melanoma	0.00162	0.00222	CcSEcCtD
Flecainide—Dry mouth—Temozolomide—melanoma	0.00161	0.00222	CcSEcCtD
Flecainide—Jaundice—Docetaxel—melanoma	0.00161	0.00221	CcSEcCtD
Flecainide—Pain—Bleomycin—melanoma	0.0016	0.0022	CcSEcCtD
Flecainide—Thrombocytopenia—Carmustine—melanoma	0.0016	0.0022	CcSEcCtD
Flecainide—Tachycardia—Carmustine—melanoma	0.0016	0.0022	CcSEcCtD
Flecainide—Confusional state—Temozolomide—melanoma	0.00159	0.00219	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00159	0.00219	CcSEcCtD
Flecainide—Oedema—Temozolomide—melanoma	0.00158	0.00217	CcSEcCtD
Flecainide—Anorexia—Carmustine—melanoma	0.00156	0.00214	CcSEcCtD
Flecainide—Nervous system disorder—Temozolomide—melanoma	0.00155	0.00213	CcSEcCtD
Flecainide—Thrombocytopenia—Temozolomide—melanoma	0.00155	0.00213	CcSEcCtD
Flecainide—Feeling abnormal—Bleomycin—melanoma	0.00154	0.00212	CcSEcCtD
Flecainide—Agranulocytosis—Docetaxel—melanoma	0.00154	0.00212	CcSEcCtD
Flecainide—Skin disorder—Temozolomide—melanoma	0.00154	0.00211	CcSEcCtD
Flecainide—Hypotension—Carmustine—melanoma	0.00153	0.0021	CcSEcCtD
Flecainide—Hyperhidrosis—Temozolomide—melanoma	0.00153	0.0021	CcSEcCtD
Flecainide—Decreased appetite—Dactinomycin—melanoma	0.00152	0.00209	CcSEcCtD
Flecainide—Fatigue—Dactinomycin—melanoma	0.00151	0.00207	CcSEcCtD
Flecainide—Anorexia—Temozolomide—melanoma	0.00151	0.00207	CcSEcCtD
Flecainide—Pain—Dactinomycin—melanoma	0.00149	0.00206	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Carmustine—melanoma	0.00149	0.00205	CcSEcCtD
Flecainide—Urticaria—Bleomycin—melanoma	0.00149	0.00205	CcSEcCtD
Flecainide—Body temperature increased—Bleomycin—melanoma	0.00148	0.00204	CcSEcCtD
Flecainide—Insomnia—Carmustine—melanoma	0.00148	0.00203	CcSEcCtD
Flecainide—Hypoaesthesia—Docetaxel—melanoma	0.00147	0.00202	CcSEcCtD
Flecainide—Paraesthesia—Carmustine—melanoma	0.00147	0.00202	CcSEcCtD
Flecainide—Dyspnoea—Carmustine—melanoma	0.00146	0.00201	CcSEcCtD
Flecainide—Somnolence—Carmustine—melanoma	0.00145	0.002	CcSEcCtD
Flecainide—Feeling abnormal—Dactinomycin—melanoma	0.00144	0.00198	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00144	0.00198	CcSEcCtD
Flecainide—Insomnia—Temozolomide—melanoma	0.00143	0.00197	CcSEcCtD
Flecainide—Gastrointestinal pain—Dactinomycin—melanoma	0.00143	0.00197	CcSEcCtD
Flecainide—Visual impairment—Docetaxel—melanoma	0.00143	0.00196	CcSEcCtD
Flecainide—Decreased appetite—Carmustine—melanoma	0.00142	0.00196	CcSEcCtD
Flecainide—Paraesthesia—Temozolomide—melanoma	0.00142	0.00195	CcSEcCtD
Flecainide—Gastrointestinal disorder—Carmustine—melanoma	0.00141	0.00194	CcSEcCtD
Flecainide—Dyspnoea—Temozolomide—melanoma	0.00141	0.00194	CcSEcCtD
Flecainide—Somnolence—Temozolomide—melanoma	0.00141	0.00193	CcSEcCtD
Flecainide—Pain—Carmustine—melanoma	0.0014	0.00192	CcSEcCtD
Flecainide—Constipation—Carmustine—melanoma	0.0014	0.00192	CcSEcCtD
Flecainide—Dyspepsia—Temozolomide—melanoma	0.00139	0.00191	CcSEcCtD
Flecainide—Eye disorder—Docetaxel—melanoma	0.00138	0.0019	CcSEcCtD
Flecainide—Body temperature increased—Dactinomycin—melanoma	0.00138	0.0019	CcSEcCtD
Flecainide—Abdominal pain—Dactinomycin—melanoma	0.00138	0.0019	CcSEcCtD
Flecainide—Decreased appetite—Temozolomide—melanoma	0.00137	0.00189	CcSEcCtD
Flecainide—Flushing—Docetaxel—melanoma	0.00137	0.00189	CcSEcCtD
Flecainide—Gastrointestinal disorder—Temozolomide—melanoma	0.00136	0.00188	CcSEcCtD
Flecainide—Fatigue—Temozolomide—melanoma	0.00136	0.00187	CcSEcCtD
Flecainide—Constipation—Temozolomide—melanoma	0.00135	0.00186	CcSEcCtD
Flecainide—Pain—Temozolomide—melanoma	0.00135	0.00186	CcSEcCtD
Flecainide—Feeling abnormal—Carmustine—melanoma	0.00135	0.00185	CcSEcCtD
Flecainide—Asthenia—Bleomycin—melanoma	0.00134	0.00185	CcSEcCtD
Flecainide—Gastrointestinal pain—Carmustine—melanoma	0.00134	0.00184	CcSEcCtD
Flecainide—Immune system disorder—Docetaxel—melanoma	0.00134	0.00184	CcSEcCtD
Flecainide—Pruritus—Bleomycin—melanoma	0.00133	0.00182	CcSEcCtD
Flecainide—Alopecia—Docetaxel—melanoma	0.00131	0.0018	CcSEcCtD
Flecainide—Feeling abnormal—Temozolomide—melanoma	0.0013	0.00179	CcSEcCtD
Flecainide—Abdominal pain—Carmustine—melanoma	0.00129	0.00178	CcSEcCtD
Flecainide—Body temperature increased—Carmustine—melanoma	0.00129	0.00178	CcSEcCtD
Flecainide—Gastrointestinal pain—Temozolomide—melanoma	0.00129	0.00178	CcSEcCtD
Flecainide—Dysgeusia—Docetaxel—melanoma	0.00126	0.00173	CcSEcCtD
Flecainide—Urticaria—Temozolomide—melanoma	0.00126	0.00173	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—melanoma	0.00125	0.00172	CcSEcCtD
Flecainide—Abdominal pain—Temozolomide—melanoma	0.00125	0.00172	CcSEcCtD
Flecainide—Body temperature increased—Temozolomide—melanoma	0.00125	0.00172	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—melanoma	0.0012	0.00164	CcSEcCtD
Flecainide—Vomiting—Bleomycin—melanoma	0.00119	0.00164	CcSEcCtD
Flecainide—Rash—Bleomycin—melanoma	0.00118	0.00163	CcSEcCtD
Flecainide—Dermatitis—Bleomycin—melanoma	0.00118	0.00162	CcSEcCtD
Flecainide—Asthenia—Carmustine—melanoma	0.00117	0.00161	CcSEcCtD
Flecainide—Syncope—Docetaxel—melanoma	0.00116	0.00159	CcSEcCtD
Flecainide—Leukopenia—Docetaxel—melanoma	0.00115	0.00159	CcSEcCtD
Flecainide—Palpitations—Docetaxel—melanoma	0.00114	0.00157	CcSEcCtD
Flecainide—Asthenia—Temozolomide—melanoma	0.00113	0.00156	CcSEcCtD
Flecainide—Loss of consciousness—Docetaxel—melanoma	0.00113	0.00156	CcSEcCtD
Flecainide—Cough—Docetaxel—melanoma	0.00112	0.00155	CcSEcCtD
Flecainide—Diarrhoea—Carmustine—melanoma	0.00112	0.00154	CcSEcCtD
Flecainide—Pruritus—Temozolomide—melanoma	0.00112	0.00154	CcSEcCtD
Flecainide—Convulsion—Docetaxel—melanoma	0.00112	0.00153	CcSEcCtD
Flecainide—Nausea—Bleomycin—melanoma	0.00111	0.00153	CcSEcCtD
Flecainide—Hypertension—Docetaxel—melanoma	0.00111	0.00153	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—melanoma	0.00111	0.00153	CcSEcCtD
Flecainide—Rash—Dactinomycin—melanoma	0.0011	0.00152	CcSEcCtD
Flecainide—Arthralgia—Docetaxel—melanoma	0.0011	0.00151	CcSEcCtD
Flecainide—Chest pain—Docetaxel—melanoma	0.0011	0.00151	CcSEcCtD
Flecainide—Myalgia—Docetaxel—melanoma	0.0011	0.00151	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00109	0.0015	CcSEcCtD
Flecainide—Dizziness—Carmustine—melanoma	0.00108	0.00149	CcSEcCtD
Flecainide—Diarrhoea—Temozolomide—melanoma	0.00108	0.00149	CcSEcCtD
Flecainide—Dry mouth—Docetaxel—melanoma	0.00107	0.00148	CcSEcCtD
Flecainide—Confusional state—Docetaxel—melanoma	0.00106	0.00146	CcSEcCtD
Flecainide—Oedema—Docetaxel—melanoma	0.00105	0.00145	CcSEcCtD
Flecainide—Dizziness—Temozolomide—melanoma	0.00105	0.00144	CcSEcCtD
Flecainide—Vomiting—Carmustine—melanoma	0.00104	0.00143	CcSEcCtD
Flecainide—Nausea—Dactinomycin—melanoma	0.00104	0.00143	CcSEcCtD
Flecainide—Shock—Docetaxel—melanoma	0.00103	0.00142	CcSEcCtD
Flecainide—Rash—Carmustine—melanoma	0.00103	0.00142	CcSEcCtD
Flecainide—Nervous system disorder—Docetaxel—melanoma	0.00103	0.00142	CcSEcCtD
Flecainide—Dermatitis—Carmustine—melanoma	0.00103	0.00142	CcSEcCtD
Flecainide—Thrombocytopenia—Docetaxel—melanoma	0.00103	0.00142	CcSEcCtD
Flecainide—Tachycardia—Docetaxel—melanoma	0.00103	0.00141	CcSEcCtD
Flecainide—Headache—Carmustine—melanoma	0.00102	0.00141	CcSEcCtD
Flecainide—Skin disorder—Docetaxel—melanoma	0.00102	0.0014	CcSEcCtD
Flecainide—CYP2D6—Biological oxidations—UGT2B10—melanoma	0.00101	0.00379	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—UGT2B10—melanoma	0.00101	0.00376	CbGpPWpGaD
Flecainide—Vomiting—Temozolomide—melanoma	0.001	0.00138	CcSEcCtD
Flecainide—Anorexia—Docetaxel—melanoma	0.001	0.00138	CcSEcCtD
Flecainide—Rash—Temozolomide—melanoma	0.000997	0.00137	CcSEcCtD
Flecainide—Dermatitis—Temozolomide—melanoma	0.000996	0.00137	CcSEcCtD
Flecainide—Headache—Temozolomide—melanoma	0.00099	0.00136	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—EPHA2—melanoma	0.000987	0.00369	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PAX4—melanoma	0.000987	0.00369	CbGpPWpGaD
Flecainide—Hypotension—Docetaxel—melanoma	0.000982	0.00135	CcSEcCtD
Flecainide—Nausea—Carmustine—melanoma	0.000972	0.00134	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000958	0.00132	CcSEcCtD
Flecainide—CYP2D6—Melatonin metabolism and effects—EDN1—melanoma	0.000956	0.00357	CbGpPWpGaD
Flecainide—Insomnia—Docetaxel—melanoma	0.000951	0.00131	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—melanoma	0.000944	0.0013	CcSEcCtD
Flecainide—Nausea—Temozolomide—melanoma	0.000939	0.00129	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—melanoma	0.000937	0.00129	CcSEcCtD
Flecainide—Somnolence—Docetaxel—melanoma	0.000934	0.00129	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—melanoma	0.000925	0.00127	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—RHOB—melanoma	0.000918	0.00343	CbGpPWpGaD
Flecainide—Decreased appetite—Docetaxel—melanoma	0.000914	0.00126	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—DCC—melanoma	0.000909	0.0034	CbGpPWpGaD
Flecainide—Gastrointestinal disorder—Docetaxel—melanoma	0.000907	0.00125	CcSEcCtD
Flecainide—Fatigue—Docetaxel—melanoma	0.000906	0.00125	CcSEcCtD
Flecainide—Constipation—Docetaxel—melanoma	0.000899	0.00124	CcSEcCtD
Flecainide—Pain—Docetaxel—melanoma	0.000899	0.00124	CcSEcCtD
Flecainide—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	0.000896	0.00335	CbGpPWpGaD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000892	0.00333	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SCN10A—melanoma	0.00088	0.00329	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—RHOB—melanoma	0.000872	0.00326	CbGpPWpGaD
Flecainide—Feeling abnormal—Docetaxel—melanoma	0.000866	0.00119	CcSEcCtD
Flecainide—SCN5A—Axon guidance—DCC—melanoma	0.000863	0.00323	CbGpPWpGaD
Flecainide—Gastrointestinal pain—Docetaxel—melanoma	0.00086	0.00118	CcSEcCtD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.00085	0.00318	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000848	0.00317	CbGpPWpGaD
Flecainide—Abdominal pain—Docetaxel—melanoma	0.000831	0.00114	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—melanoma	0.000831	0.00114	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—RAC2—melanoma	0.000823	0.00308	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL10—melanoma	0.00079	0.00295	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CDH2—melanoma	0.000786	0.00294	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000785	0.00293	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ITGAV—melanoma	0.000782	0.00292	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—RAC2—melanoma	0.000782	0.00292	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000778	0.00291	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000775	0.0029	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000768	0.00287	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—MAP2K1—melanoma	0.000765	0.00286	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—CYP1B1—melanoma	0.000758	0.00283	CbGpPWpGaD
Flecainide—Asthenia—Docetaxel—melanoma	0.000754	0.00104	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—NODAL—melanoma	0.000748	0.0028	CbGpPWpGaD
Flecainide—Pruritus—Docetaxel—melanoma	0.000744	0.00102	CcSEcCtD
Flecainide—SCN4A—L1CAM interactions—MAPK3—melanoma	0.000722	0.0027	CbGpPWpGaD
Flecainide—Diarrhoea—Docetaxel—melanoma	0.000719	0.000989	CcSEcCtD
Flecainide—SCN4A—Axon guidance—ITGB1—melanoma	0.00071	0.00265	CbGpPWpGaD
Flecainide—Dizziness—Docetaxel—melanoma	0.000695	0.000956	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—PAX6—melanoma	0.000692	0.00259	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—MAPK1—melanoma	0.000687	0.00257	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—EGFR—melanoma	0.000687	0.00257	CbGpPWpGaD
Flecainide—Vomiting—Docetaxel—melanoma	0.000668	0.000919	CcSEcCtD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000666	0.00249	CbGpPWpGaD
Flecainide—Rash—Docetaxel—melanoma	0.000663	0.000912	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—melanoma	0.000662	0.000911	CcSEcCtD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000661	0.00247	CbGpPWpGaD
Flecainide—Headache—Docetaxel—melanoma	0.000659	0.000906	CcSEcCtD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000655	0.00245	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000652	0.00244	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000647	0.00242	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	0.000645	0.00241	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—AKR1B10—melanoma	0.000639	0.00239	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000637	0.00238	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000631	0.00236	CbGpPWpGaD
Flecainide—Nausea—Docetaxel—melanoma	0.000624	0.000859	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—RHOB—melanoma	0.000622	0.00233	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—DCC—melanoma	0.000616	0.0023	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ITGB3—melanoma	0.000616	0.0023	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MAP2K2—melanoma	0.000602	0.00225	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000591	0.00221	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—RAC1—melanoma	0.000571	0.00213	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT3—melanoma	0.000558	0.00209	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ITGAV—melanoma	0.000558	0.00209	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RAC2—melanoma	0.000558	0.00208	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000536	0.002	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CDH2—melanoma	0.000533	0.00199	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000531	0.00199	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ITGAV—melanoma	0.00053	0.00198	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—KDR—melanoma	0.000523	0.00196	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MET—melanoma	0.000512	0.00191	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ITGB1—melanoma	0.000507	0.00189	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—MAPK3—melanoma	0.000489	0.00183	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ITGB1—melanoma	0.000481	0.0018	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PAX6—melanoma	0.000469	0.00175	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—MAPK1—melanoma	0.000466	0.00174	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—EGFR—melanoma	0.000466	0.00174	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	0.000462	0.00173	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ITGB3—melanoma	0.000439	0.00164	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000432	0.00161	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MAP2K2—melanoma	0.000429	0.00161	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MMP2—melanoma	0.000427	0.0016	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MAP2K1—melanoma	0.000427	0.00159	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000422	0.00158	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ITGB3—melanoma	0.000417	0.00156	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CASP3—melanoma	0.000413	0.00155	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MAP2K2—melanoma	0.000408	0.00152	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—RAC1—melanoma	0.000407	0.00152	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000398	0.00149	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—RAC1—melanoma	0.000387	0.00145	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000387	0.00144	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ITGAV—melanoma	0.000378	0.00141	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT3—melanoma	0.000378	0.00141	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ERBB2—melanoma	0.000374	0.0014	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KDR—melanoma	0.000374	0.0014	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CDK4—melanoma	0.000366	0.00137	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MET—melanoma	0.000366	0.00137	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KDR—melanoma	0.000355	0.00133	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NOTCH1—melanoma	0.000352	0.00132	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000351	0.00131	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MET—melanoma	0.000347	0.0013	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ITGB1—melanoma	0.000343	0.00128	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000342	0.00128	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.000338	0.00126	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.000335	0.00125	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.000333	0.00125	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARG—melanoma	0.000332	0.00124	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000331	0.00124	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MMP9—melanoma	0.000321	0.0012	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MMP2—melanoma	0.000305	0.00114	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MAP2K1—melanoma	0.000304	0.00114	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—melanoma	0.000301	0.00112	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ITGB3—melanoma	0.000298	0.00111	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MAP2K2—melanoma	0.000291	0.00109	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MMP2—melanoma	0.00029	0.00108	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—FGF2—melanoma	0.00029	0.00108	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MAP2K1—melanoma	0.000289	0.00108	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—VEGFA—melanoma	0.000288	0.00108	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—NRAS—melanoma	0.000285	0.00106	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP1B1—melanoma	0.000285	0.00106	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000282	0.00105	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	0.000281	0.00105	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000278	0.00104	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RAC1—melanoma	0.000276	0.00103	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MAPK3—melanoma	0.000273	0.00102	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ERBB2—melanoma	0.000267	0.000999	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MAPK1—melanoma	0.00026	0.00097	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—EGFR—melanoma	0.00026	0.00097	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000256	0.000956	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ERBB2—melanoma	0.000254	0.000949	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KDR—melanoma	0.000253	0.000946	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MET—melanoma	0.000248	0.000926	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CDK4—melanoma	0.000248	0.000926	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—KRAS—melanoma	0.000245	0.000916	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL6—melanoma	0.000243	0.000907	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NOTCH1—melanoma	0.000239	0.000892	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CTNNB1—melanoma	0.000234	0.000874	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MMP9—melanoma	0.000229	0.000857	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NFKB1—melanoma	0.000227	0.000848	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARG—melanoma	0.000225	0.000842	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MMP9—melanoma	0.000218	0.000814	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000214	0.000798	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—HRAS—melanoma	0.000208	0.000779	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP2—melanoma	0.000207	0.000773	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MAP2K1—melanoma	0.000206	0.000772	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—melanoma	0.000206	0.000769	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—STAT3—melanoma	0.000204	0.000762	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NRAS—melanoma	0.000203	0.00076	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.0002	0.000747	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—melanoma	0.000199	0.000746	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—FGF2—melanoma	0.000196	0.000734	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—VEGFA—melanoma	0.000195	0.000731	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MAPK3—melanoma	0.000195	0.000728	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—NRAS—melanoma	0.000193	0.000722	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACER3—melanoma	0.00019	0.000709	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACER3—melanoma	0.000188	0.000703	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MAPK1—melanoma	0.000185	0.000692	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—EGFR—melanoma	0.000185	0.000692	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MAPK3—melanoma	0.000185	0.000691	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ERBB2—melanoma	0.000181	0.000677	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—melanoma	0.000176	0.000659	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MAPK1—melanoma	0.000176	0.000658	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—EGFR—melanoma	0.000176	0.000658	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KRAS—melanoma	0.000175	0.000654	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UGT2B10—melanoma	0.000174	0.000649	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UGT2B10—melanoma	0.000172	0.000643	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00017	0.000635	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KRAS—melanoma	0.000166	0.000621	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HS3ST5—melanoma	0.000161	0.000603	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HS3ST5—melanoma	0.00016	0.000598	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CTNNB1—melanoma	0.000158	0.000592	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—melanoma	0.000155	0.000581	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NFKB1—melanoma	0.000154	0.000575	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—HRAS—melanoma	0.000149	0.000556	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—melanoma	0.000142	0.000532	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—HRAS—melanoma	0.000141	0.000528	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—melanoma	0.000139	0.000521	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—STAT3—melanoma	0.000138	0.000516	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NRAS—melanoma	0.000138	0.000515	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—melanoma	0.000135	0.000505	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MAPK3—melanoma	0.000132	0.000493	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—melanoma	0.000131	0.000491	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000129	0.000481	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MAPK1—melanoma	0.000126	0.000469	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EGFR—melanoma	0.000126	0.000469	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLCB4—melanoma	0.000122	0.000457	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLCB4—melanoma	0.000121	0.000453	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—melanoma	0.00012	0.000447	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000119	0.000445	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KRAS—melanoma	0.000119	0.000443	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC6A11—melanoma	0.000115	0.00043	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIP4K2A—melanoma	0.000115	0.00043	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIP4K2A—melanoma	0.000114	0.000426	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC6A11—melanoma	0.000114	0.000426	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTAP—melanoma	0.000112	0.000418	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTAP—melanoma	0.000111	0.000414	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000108	0.000405	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—HRAS—melanoma	0.000101	0.000377	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PHGDH—melanoma	9.97e-05	0.000373	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LUM—melanoma	9.97e-05	0.000373	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LUM—melanoma	9.88e-05	0.000369	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PHGDH—melanoma	9.88e-05	0.000369	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HPSE—melanoma	9.77e-05	0.000365	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HPSE—melanoma	9.69e-05	0.000362	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—melanoma	9.65e-05	0.000361	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CUBN—melanoma	9.59e-05	0.000359	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CUBN—melanoma	9.51e-05	0.000355	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BSG—melanoma	9.27e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CSPG4—melanoma	9.27e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SDHD—melanoma	9.27e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SDHD—melanoma	9.19e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CSPG4—melanoma	9.19e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BSG—melanoma	9.19e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPAM—melanoma	8.97e-05	0.000335	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—melanoma	8.9e-05	0.000333	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPAM—melanoma	8.9e-05	0.000333	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLA2G6—melanoma	7.63e-05	0.000285	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLA2G6—melanoma	7.56e-05	0.000283	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—VCAN—melanoma	6.85e-05	0.000256	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—VCAN—melanoma	6.79e-05	0.000254	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.43e-05	0.00024	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.21e-05	0.000232	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP17A1—melanoma	5.78e-05	0.000216	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP17A1—melanoma	5.73e-05	0.000214	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.65e-05	0.000211	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	5.58e-05	0.000209	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GNA11—melanoma	5.46e-05	0.000204	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GNA11—melanoma	5.41e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FASN—melanoma	5.34e-05	0.0002	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FASN—melanoma	5.3e-05	0.000198	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A5—melanoma	5.26e-05	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A5—melanoma	5.21e-05	0.000195	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GNAQ—melanoma	5.08e-05	0.00019	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CD44—melanoma	5.08e-05	0.00019	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GNAQ—melanoma	5.03e-05	0.000188	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CD44—melanoma	5.03e-05	0.000188	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.93e-05	0.000184	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.88e-05	0.000183	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1B1—melanoma	4.87e-05	0.000182	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1B1—melanoma	4.82e-05	0.00018	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.26e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCB1—melanoma	4.01e-05	0.00015	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCB1—melanoma	3.97e-05	0.000149	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PRKCA—melanoma	3.69e-05	0.000138	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ERCC2—melanoma	3.66e-05	0.000137	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PRKCA—melanoma	3.66e-05	0.000137	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ERCC2—melanoma	3.63e-05	0.000136	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3e-05	0.000112	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CG—melanoma	2.89e-05	0.000108	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CG—melanoma	2.86e-05	0.000107	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARG—melanoma	2.79e-05	0.000104	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARG—melanoma	2.76e-05	0.000103	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CD—melanoma	2.54e-05	9.49e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CD—melanoma	2.52e-05	9.41e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALB—melanoma	2.51e-05	9.37e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALB—melanoma	2.49e-05	9.29e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CB—melanoma	2.21e-05	8.28e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CB—melanoma	2.19e-05	8.2e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—melanoma	2.19e-05	8.2e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—melanoma	2.17e-05	8.13e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTEN—melanoma	1.91e-05	7.15e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTEN—melanoma	1.9e-05	7.09e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CA—melanoma	1.35e-05	5.04e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CA—melanoma	1.34e-05	5e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—melanoma	1.1e-05	4.12e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—melanoma	1.09e-05	4.09e-05	CbGpPWpGaD
